NCT03322085

Brief Summary

This study explored the influence of radiofrequency catheter ablation and cryoballoon ablation on atrial electrical remodeling in patients with atrial fibrillation,the relationship between atrial electrical remodeling and structural remodeling,and which indicators are associated with atrial recurrence after catheter ablation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
126

participants targeted

Target at P25-P50 for not_applicable atrial-fibrillation

Timeline
Completed

Started Sep 2017

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2017

Completed
27 days until next milestone

First Submitted

Initial submission to the registry

September 28, 2017

Completed
28 days until next milestone

First Posted

Study publicly available on registry

October 26, 2017

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2019

Completed
29 days until next milestone

Study Completion

Last participant's last visit for all outcomes

October 30, 2019

Completed
Last Updated

March 18, 2021

Status Verified

March 1, 2020

Enrollment Period

2.1 years

First QC Date

September 28, 2017

Last Update Submit

March 17, 2021

Conditions

Keywords

atrial fibrillationatrial electrical remodeling

Outcome Measures

Primary Outcomes (2)

  • Change of P wave

    Electrocardiogram

    1-12 month

  • Atrial effective refractory period

    Electrophysiological examination

    During the operation

Secondary Outcomes (6)

  • Plasma biomarkers of inflammation assessed

    1-12 month

  • B type natriuretic peptide assessed

    1-12 month

  • Left atrial function

    1-12month

  • Coagulation index assessed

    1-6 month

  • homocysteine assessed

    1-12 month

  • +1 more secondary outcomes

Study Arms (3)

paroxysmal AF with radiofrequency ablation

EXPERIMENTAL

radiofrequency catheter ablation therapy

Procedure: radiofrequency ablation or cryoballoon

persistent AF with radiofrequency ablation group

EXPERIMENTAL

radiofrequency catheter ablation therapy

Procedure: radiofrequency ablation or cryoballoon

paroxysmal AF with cryoballoon group

EXPERIMENTAL

cryoballoon ablation therapy

Procedure: radiofrequency ablation or cryoballoon

Interventions

Patients in radiofrequency ablation group receive circumferential pulmonary vein isolation,and no additional ablation is performed in the extrapulmonary sites unless the patient is diagnosed with atrial flutter before the operation. And Cryoablation is performed using a single cryoballoon. The diameter of the cryoballoon is determined as 28 mm or 23 mm according to pulmonary venography results.

paroxysmal AF with cryoballoon groupparoxysmal AF with radiofrequency ablationpersistent AF with radiofrequency ablation group

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • paroxysmal AF episode occurs in the patient at least twice within half a year (electrocardiogram data or Holter), AF cannot be prevented in patients who orally take class I and III antiarrhythmic drugs, and patient age is ≤80 years.

You may not qualify if:

  • patients with previous history of AF ablation, atrial thrombosis, or valvular heart disease (moderate and severe valvular stenosis, severe valvular regurgitation), left atrium (LA) \>50 mm, patients who underwent prosthetic heart valve replacement, pregnant women, patients with existing liver and kidney disease, malignant tumors or hematological system diseases.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Second Hospital of Hebei Medical University

Shijiazhuang, Hebei, 050000, China

Location

MeSH Terms

Conditions

Atrial Fibrillation

Interventions

Radiofrequency Ablation

Condition Hierarchy (Ancestors)

Arrhythmias, CardiacHeart DiseasesCardiovascular DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Radiofrequency TherapyTherapeuticsAblation TechniquesSurgical Procedures, Operative

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
director of cardiology department

Study Record Dates

First Submitted

September 28, 2017

First Posted

October 26, 2017

Study Start

September 1, 2017

Primary Completion

October 1, 2019

Study Completion

October 30, 2019

Last Updated

March 18, 2021

Record last verified: 2020-03

Locations